Crossref
EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Value in Health · 2026-06 · 29 (6) · S154
DOI: 10.1016/j.jval.2026.03.779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Adam J. Raymakers und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Raymakers, A. J., Kesselheim, A. S., & Feldman, W. B. (2026). EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA. Value in Health, 29(6), S154. https://doi.org/10.1016/j.jval.2026.03.779
Vancouver
Raymakers AJ, Kesselheim AS, Feldman WB. EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA. Value in Health. 2026;29(6):S154. doi:10.1016/j.jval.2026.03.779
BibTeX
@article{Raymakers2026,
author = {Raymakers, Adam J. and Kesselheim, Aaron S. and Feldman, William B.},
title = {EE486 SPENDING ON GENE THERAPIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S154},
doi = {10.1016/j.jval.2026.03.779}
}
EUVIMED